From the Desk of the Office of Combination Products: Strategic Priorities & Action

FDA’s Office of Combination Products serves as a liaison between industry and the necessary FDA Centers on the most pressing challenges faced by the Combination Products Industry. Learn firsthand what is being addressed by FDA now, and what is planned for the future on traditional and complex products.

Moderator

• Timothy W. Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative

Speakers

• James Bertram, Director of the Office of Combination Products (OCP), FDA
• John “Barr” Weiner, Associate Director for Policy in FDA’s Office of Combination Products (OCP), FDA